- Home
- ODC vs KROS Comparison
ODC vs KROS Comparison
Compare ODC & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODC
- KROS
- Stock Information
- Founded
- ODC 1941
- KROS 2015
- Country
- ODC United States
- KROS United States
- Employees
- ODC N/A
- KROS N/A
- Industry
- ODC Miscellaneous manufacturing industries
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- ODC Consumer Discretionary
- KROS Health Care
- Exchange
- ODC Nasdaq
- KROS Nasdaq
- Market Cap
- ODC 310.1M
- KROS 589.8M
- IPO Year
- ODC N/A
- KROS 2020
- Fundamental
- Price
- ODC $42.90
- KROS $11.02
- Analyst Decision
- ODC
- KROS Buy
- Analyst Count
- ODC 0
- KROS 11
- Target Price
- ODC N/A
- KROS $45.33
- AVG Volume (30 Days)
- ODC 36.3K
- KROS 2.0M
- Earning Date
- ODC 03-06-2025
- KROS 02-26-2025
- Dividend Yield
- ODC 1.44%
- KROS N/A
- EPS Growth
- ODC 36.22
- KROS N/A
- EPS
- ODC 3.09
- KROS N/A
- Revenue
- ODC $454,094,000.00
- KROS $651,000.00
- Revenue This Year
- ODC N/A
- KROS $303.27
- Revenue Next Year
- ODC N/A
- KROS N/A
- P/E Ratio
- ODC $13.78
- KROS N/A
- Revenue Growth
- ODC 6.61
- KROS 8037.50
- 52 Week Low
- ODC $29.48
- KROS $9.78
- 52 Week High
- ODC $46.50
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- ODC 60.19
- KROS 22.23
- Support Level
- ODC $42.18
- KROS $9.78
- Resistance Level
- ODC $42.45
- KROS $11.63
- Average True Range (ATR)
- ODC 1.20
- KROS 0.85
- MACD
- ODC -0.15
- KROS 1.14
- Stochastic Oscillator
- ODC 76.53
- KROS 21.16
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.